What is Plenful?
Based in San Francisco, California, Plenful operates as an automated operations platform provider specifically tailored for the pharmacy and healthcare industries. The company focuses on streamlining complex operational workflows, enhancing efficiency, and reducing administrative burdens within these critical sectors. By leveraging technology to automate key processes, Plenful aims to improve patient care and operational outcomes for its clients, positioning itself as a key player in the health-tech innovation landscape.
How much funding has Plenful raised?
Plenful has raised a total of $76M across 3 funding rounds:
Other Financing Round
$9M
Series A
$17M
Series B
$50M
Other Financing Round (2023): $9M with participation from Bessemer Venture Partners
Series A (2024): $17M led by Bessemer Venture Partners, TQ Ventures, and Susa Ventures
Series B (2025): $50M supported by Danaher, Notable Capital, The Arena Group, and Bessemer Venture Partners
Key Investors in Plenful
Danaher
Danaher Corporation is a global science and technology innovator across biotechnology, life sciences, and diagnostics, providing integrated solutions for therapeutic product development and manufacturing. Their involvement suggests a strategic interest in Plenful's healthcare operational efficiencies.
Bessemer Venture Partners
Bessemer Venture Partners is a long-standing venture capital firm with a history dating back to 1911, known for investing in early-stage and growth-stage companies across various sectors, including technology and healthcare. Their continued backing indicates strong confidence in Plenful's long-term vision.
TQ Ventures
TQ Ventures LLC is a venture capital firm focused on supporting extraordinary founders in the software complex, with an interest in fintech and healthcare businesses. Their investment in Plenful highlights a belief in the company's innovative approach to healthcare operations.
What's next for Plenful?
With the recent major strategic investment and substantial total funding, Plenful is poised for accelerated growth and further development of its automated operations platform. The company is likely to focus on expanding its service offerings, enhancing its technological infrastructure, and broadening its market penetration within the healthcare and pharmacy sectors. This strategic capital will enable Plenful to scale its operations, invest in research and development, and solidify its competitive advantage in a rapidly evolving industry. Future expansion may also involve strategic partnerships and acquisitions to further enhance its capabilities and market presence.
See full Plenful company page
